» Articles » PMID: 37523093

Thymoquinone-loaded Self-nano-emulsifying Drug Delivery System Against Ischemia/reperfusion Injury

Overview
Publisher Springer
Specialty Pharmacology
Date 2023 Jul 31
PMID 37523093
Authors
Affiliations
Soon will be listed here.
Abstract

In the present study, a self-nano-emulsifying drug delivery system (SNEDDS) was developed to evaluate the efficiency of thymoquinone (TQ) in hepatic ischemia/reperfusion. SNEDDS was pharmaceutically characterized to evaluate droplet size, morphology, zeta potential, thermodynamic stability, and dissolution/diffusion capacity. Animals were orally pre-treated during 10 days with TQ-loaded SNEDDS. Biochemical analyses, hematoxylin-eosin staining, indirect immunofluorescence, and reverse transcription polymerase chain reaction (RT-PCR) were carried out to assess cell injury, oxidative stress, inflammation, and apoptosis. The TQ formulation showed good in vitro characteristics, including stable nanoparticle structure and size with high drug release rate. In vivo determinations revealed that TQ-loaded SNEDDS pre-treatment of rats maintained cellular integrity by decreasing transaminase (ALT and AST) release and preserving the histological characteristics of their liver. The antioxidant ability of the formulation was proven by increased SOD activity, reduced MDA concentration, and iNOS protein expression. In addition, this formulation exerted an anti-inflammatory effect evidenced by reduced plasma CRP concentration, MPO activity, and gene expressions of TLR-4, TNF-α, NF-κB, and IL-6. Finally, the TQ-loaded SNEDDS formulation promoted cell survival by enhancing the Bcl-2/Bax ratio. In conclusion, our results indicate that TQ encapsulated in SNEDDS significantly protects rat liver from I/R injury.

Citing Articles

Self-Emulsifying Drug Delivery Systems (SEDDS): Transition from Liquid to Solid-A Comprehensive Review of Formulation, Characterization, Applications, and Future Trends.

Uttreja P, Karnik I, Youssef A, Narala N, Elkanayati R, Baisa S Pharmaceutics. 2025; 17(1).

PMID: 39861711 PMC: 11768142. DOI: 10.3390/pharmaceutics17010063.

References
1.
Choi H, Kim H, Sakong J . Rates and subsequent clinical course of fetal congenital anomalies detected by prenatal targeted ultrasonography of 137 cases over 5 years in a single institute: a retrospective observational study. J Yeungnam Med Sci. 2022; 40(3):268-275. PMC: 10390279. DOI: 10.12701/jyms.2022.00514. View

2.
Mendes-Braz M, Elias-Miro M, Jimenez-Castro M, Casillas-Ramirez A, Ramalho F, Peralta C . The current state of knowledge of hepatic ischemia-reperfusion injury based on its study in experimental models. J Biomed Biotechnol. 2012; 2012:298657. PMC: 3357607. DOI: 10.1155/2012/298657. View

3.
Quesnelle K, Bystrom P, Toledo-Pereyra L . Molecular responses to ischemia and reperfusion in the liver. Arch Toxicol. 2015; 89(5):651-7. DOI: 10.1007/s00204-014-1437-x. View

4.
Wiggins B, Saseen J, Page 2nd R, Reed B, Sneed K, Kostis J . Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2016; 134(21):e468-e495. DOI: 10.1161/CIR.0000000000000456. View

5.
Gaire B . Herbal Medicine in Ischemic Stroke: Challenges and Prospective. Chin J Integr Med. 2018; 24(4):243-246. DOI: 10.1007/s11655-018-2828-2. View